Answers are grounded in this paper and cite their sources.
In order to study structure-activity relationships among the derivatives and congeners of 5',9-anhydro-3-(beta-D-ribofuranosyl)xanthine for anti-hepatitis C virus activity, a series of 5',9-anhydro-purine-isonucleosides with a substituent (s) at 6- or/and 8-position of the purine moiety were synthesized, and their anti-hepatitis C virus activity and cytotoxicity were evaluated and discussed.
No takes yet. Share an insight, caveat, or question.
Chun et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: